# Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults

> **NCT04546841** · PHASE1 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 36 (actual)

## Conditions studied

- COVID-19 Vaccine

## Interventions

- **BIOLOGICAL:** multipeptide cocktail

## Key facts

- **NCT ID:** NCT04546841
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-27
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-12-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04546841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04546841, "Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04546841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*